Skip to content

Effect of cardiac rehabilitation in patients undergone myocardial infarction and percutaneous coronary intervention

A Randomized Controlled Trial of Cardiac Rehabilitation in Myocardial Infarction Patients with Percutaneous Coronary Intervention - MY-CARE

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019948
Enrollment
382
Registered
2019-06-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I21- Acute myocardial infarction

Interventions

Intervention1: Cardiac rehabilitation: Adapted phase II and phase III of cardiac rehabilitation program with components of physical activity, education on coronary artery disease and heart-healthy liv

Sponsors

Dr JS Thakur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 18-80 years of age 2. Diagnosed myocardial infarction who have undergone percutaneous coronary intervention not at risk due to other comorbidities. 3. Willing to give informed consent 4. Individuals with Acute Myocardial Infarction 5. Patients with New York Heart Association (NYHA) functional class I, II & III symptoms

Exclusion criteria

Exclusion criteria: 1. Participants with medical conditions which could put them at risk during physical activity testing or training (e.g., angina) or conditions that could limit the participant’s ability to exercise (e.g., severe orthopaedic or neurologic impairments) 2. Individuals with Prior Myocardial Infarction

Design outcomes

Primary

MeasureTime frame
Physical activity Functional capacity Knowledge related to coronary artery disease Depression scores Medication adherenceTimepoint: 6 months

Secondary

MeasureTime frame
Health related quality of life. Anthropometric measures: Body Mass Index (BMI), Waist circumference. Risk profile and biochemical measures: BP(Blood Pressure), LDL(Low Density Lipoprotein), HDL(High Density Lipoprotein), Fasting glucose, HbA1c Cost effective implementation of cardiac rehabilitation model All-cause mortalityTimepoint: 6 months

Countries

India

Contacts

Public ContactDr JS Thakur

PGIMER

jsthakur64@gmail.com9463602173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026